The EP300-Targeting Drug CCS1477 Inhibits the Growth and Development ofDiffuse Large B-Cell Lymphoma by Promoting Apoptosis and Mitophagy to ReduceDrug Resistance

Rujia Si(Jiangsu Cancer Hospital), Bo Shen(Xuzhou Medical College), Shanlin Fu(North China University of Science and Technology), Shiying Zhu(The University of Melbourne), Bowen Hu(Jiangsu Cancer Hospital), Xiaofeng Sha(Xuzhou Medical College), Shaodi Wen(Jiangsu Cancer Hospital), Xin Chen(Shandong University of Traditional Chinese Medicine), Peng Chen(Jiangsu Cancer Hospital), Fan Du(Jiangsu Cancer Hospital), Cong Xu(Liaocheng People's Hospital), Xiaoyue Du(Inner Mongolia Agricultural University), Ning Ding(Shanghai Medical College of Fudan University), Dan Zou(Guangzhou Development Zone Hospital), Yuxin Du(California Institute for Regenerative Medicine)
Anti-Cancer Agents in Medicinal Chemistry
October 10, 2025
Cited by 1


Related Papers